STOK — STOKE THERAPEUTICS INC

Ownership history in Checkpoint Capital L.P.  ·  4 quarters on record

This page tracks every 13F SEC filing in which Checkpoint Capital L.P. reported a position in STOKE THERAPEUTICS INC (STOK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.67% (2025 Q1)
Avg. % of fund
1.75%
First filed
2024 Q3
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 212,049 -518,668 -71.0% 1.67% $5.0M $23.50
2025 Q1 ADDED 730,717 +425,330 +139.3% 2.67% $4.9M $6.65
2024 Q4 ADDED 305,387 +147,873 +93.9% 1.71% $3.4M $11.03
2024 Q3 INITIATED 157,514 — — 0.96% $1.9M $12.29
% of Fund (quarterly)    STOK price (monthly, adj. close)

Other funds also holding STOK

As of 2025 Q4 — sorted by position size

Lynx1 Capital Management LP 3Y 34.73% Redmile Group, LLC 3Y 7Y 9.43% Birchview Capital, LP 3Y 7Y 4.83% Opaleye Management Inc. 3Y 7Y 2.91% MPM BioImpact LLC 3Y 2.8% BVF INC/IL 3Y 7Y 2.42% Siren, L.L.C. 2.13% RTW INVESTMENTS, LP 3Y 7Y 1.76% Quantedge Capital Pte Ltd 3Y 1.32% Parkman Healthcare Partners LLC 3Y 1.3%
← Back to Checkpoint Capital L.P. Holdings